Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsPAR-25-183

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

National Institutes of Health opportunity PAR-25-183

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-25-183Grants.gov
Related Grants
Health● Open
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
Varies
14 Oct 2026(12d)
Health● Open
Protecting and Improving Global Health Security by Engaging Local Partners: Strengthening and Sustaining Public Health Systems in Ghana
Varies
02 Oct 2026(0d)
Health● Open
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
Varies
16 Mar 2027(165d)
Health● Open
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
Varies
08 Oct 2027(371d)
Funding Amount
Varies
USD
Application Deadline
15 October 2027
378 days remaining
Opens: 26 Nov 2024
Apply Now
Programme Details
Programme Code
PAR-25-183